
CAS: 2011769-21-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | DSM421 REF: 54-BUP15206CAS: 2011769-21-2 | ≥98% | 1,112.00 €~3,277.00 € | Tue 06 May 25 |
![]() | DSM421 REF: TM-T27214CAS: 2011769-21-2 | 99.82% - 99.93% | 116.00 €~1,320.00 € | Mon 23 Jun 25 |

Ref: 54-BUP15206
1g | 3,277.00 € | ||
50mg | 1,112.00 € | ||
100mg | 1,350.00 € | ||
200mg | 1,788.00 € | ||
500mg | 2,334.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025

DSM421
CAS:2011769-21-2
DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential …
Formula:
C14H11F5N6
Purity:
99.82% - 99.93%
Color and Shape:
Solid
Molecular weight:
358.27
Ref: TM-T27214
1mg | 116.00 € | ||
5mg | 273.00 € | ||
10mg | 373.00 € | ||
25mg | 563.00 € | ||
50mg | 758.00 € | ||
100mg | 998.00 € | ||
200mg | 1,320.00 € | ||
1mL*10mM (DMSO) | 319.00 € |
Estimated delivery in United States, on Monday 23 Jun 2025